NurOwn May Curb Damaging Brain Inflammation in ALS Patients, Study Suggests
NurOwn, a cell-based therapy that protects and helps repair nerve cells, also may be able to…
Articles by Inês Martins, PhD
ProMIS Creating Intrabodies, Antibodies Targeting Protein Clumps Within Cells
ProMIS Neurosciences announced its program for amyotrophic lateral sclerosis (ALS) is advancing, and scientists were able to…
Agriculture Work and Exposure to Pollutants May Raise ALS Risk
Agriculture and other areas that expose people to pesticides, paint solvents, electromagnetic fields, and heavy metals may increase their odds…
ALS Association Supports Mobile App That Tracks Eye Movement to Help Patients
Computer scientists at Stony Brook University have been awarded $200,000 by the ALS Association to continue the development…
Blood Biomarkers May Aid in Earlier Diagnosis of ALS, Review Study Suggests
Identifying blood biomarkers that reflect the metabolic changes occurring in people with amyotrophic lateral sclerosis (ALS) may be among…
EMA Favors Giving Amylyx’s AMX0035 Orphan Medicine Status for ALS
A branch of the European Medicines Agency (EMA) has recommended that Amylyx‘s investigational oral…
Reducing Excess Firing of Motor Neurons Delays Symptoms in Animal Model of ALS
Reducing the excess firing of motor neurons in an animal model of amyotrophic lateral sclerosis (ALS) prevents the death…
Rowan Team Receives $1.6 Million to Study SOD1 in Gut-brain Communication in Worms
A team at the Rowan University School of Osteopathic Medicine has received a $1.6 million grant to study the role…
Smoking Not Seen to Raise Risk of ALS in UK Study
A weak link only between a person’s current smoking study and greater risk of amyotrophic lateral sclerosis (ALS) was…
NGS, Way of Examining Multiple Genes, May Aid ALS Diagnosis and Study
A way of examining multiple genes or the entire human genome at the same time, called next-generation sequencing (NGS), is…